| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-236 |
| PharmacoGx | KIN001-236 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ITGB5 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | YAP1 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | EXT2 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | MYOF | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | GNG12 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | PLOD1 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | IGF2BP2 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | PRSS23 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | CAST | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | ANXA2 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
